News stories about USANA Health Sciences (NYSE:USNA) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. USANA Health Sciences earned a media sentiment score of 0.04 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.5614048888558 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news headlines that may have effected Accern’s rankings:
- USANA Health Sciences (USNA) Cut to “C+” at TheStreet (americanbankingnews.com)
- USANA Health Sciences (USNA) Price Target Raised to $95.00 (americanbankingnews.com)
- USANA Health reports 4Q loss (finance.yahoo.com)
- USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 2,753 Shares (americanbankingnews.com)
- USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 8,344 Shares (americanbankingnews.com)
Shares of USANA Health Sciences (NYSE USNA) traded up $0.10 on Thursday, hitting $75.15. The stock had a trading volume of 44,167 shares, compared to its average volume of 84,930. The firm has a market capitalization of $1,697.47, a price-to-earnings ratio of 29.76 and a beta of 0.99. USANA Health Sciences has a 52 week low of $52.55 and a 52 week high of $79.00.
In related news, Director Myron W. Wentz sold 38,223 shares of USANA Health Sciences stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $71.51, for a total transaction of $2,733,326.73. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Global Ltd Gull sold 7,289 shares of USANA Health Sciences stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $66.01, for a total value of $481,146.89. Following the transaction, the insider now directly owns 11,996,192 shares in the company, valued at $791,868,633.92. The disclosure for this sale can be found here. Insiders have sold 433,455 shares of company stock worth $28,990,246 over the last three months. Corporate insiders own 53.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2018/02/08/usana-health-sciences-usna-getting-somewhat-positive-news-coverage-study-shows.html.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.